Related Experiment Video
Updated: Jun 20, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Negative modulation of inositol 1,4,5-trisphosphate type 1 receptor expression prevents dystrophin-deficient muscle
Ludivine Mondin1, Haouaria Balghi, Bruno Constantin
1Institut de Physiologie et Biologie Cellulaires, Centre National de la Recherche Scientifique UMR 6187, Université de Poitiers, 86022 Poitiers, France.
Abstract:
Evidence for a modulatory effect of cyclosporin A (CsA) on calcium signaling and cell survival in dystrophin-deficient cells is presented. Our previous works strongly supported the hypothesis of an overactivation of Ca(2+) release via inositol 1,4,5-trisphosphate (IP3) receptors (IP3R) in dystrophin-deficient cells, both during membrane depolarization and at rest, through spontaneous Ca(2+) release events. Forced expression of mini-dystrophin in these cells contributed, during stimulation and in resting condition, to the recovery of a controlled calcium homeostasis. In the present work, we demonstrate that CsA exposure displayed a dual-modulator effect on calcium signaling in dystrophin-deficient cells. Short-time incubation induced a decrease of IP3-dependent calcium release, leading to patterns of release similar to those observed in myotubes expressing mini-dystrophin, whereas long-time incubation reduced the expression of the type I of IP3 receptors (IP3R-1) RNA levels. Moreover, both IP3R-1 knockdown and blockade through 2-aminoethoxydiphenyle borate or CsA induced improved survival of dystrophin-deficient myotubes, demonstrating the cell death dependence on the IP3-dependent calcium signaling as well as the protective effect of CsA. Inhibition of the IP3 pathway could be a very interesting approach for reducing the natural cell death of dystrophin-deficient cells in development.
Insights
Cyclosporin A (CsA) modulates calcium signaling in dystrophin-deficient cells, reducing inositol 1,4,5-trisphosphate receptor activity and improving cell survival. This suggests CsA as a potential therapeutic for cell death in these conditions.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Dystrophin-deficient cells exhibit dysregulated calcium (Ca2+) signaling, characterized by overactive inositol 1,4,5-trisphosphate (IP3) receptor-mediated Ca2+ release.
- Restored calcium homeostasis was previously observed in these cells upon forced expression of mini-dystrophin.
Purpose of the Study:
- To investigate the modulatory effects of cyclosporin A (CsA) on calcium signaling and cell survival in dystrophin-deficient cells.
- To explore the potential of inhibiting the IP3 pathway as a therapeutic strategy.
Main Methods:
- Exposure of dystrophin-deficient cells to CsA for varying durations.
- Measurement of IP3-dependent calcium release.
- Analysis of IP3 receptor type 1 (IP3R-1) RNA levels.
- Assessment of cell survival following IP3R-1 knockdown or blockade.
Main Results:
- Short-term CsA incubation decreased IP3-dependent calcium release, mimicking effects of mini-dystrophin expression.
- Long-term CsA incubation reduced IP3R-1 RNA levels.
- IP3R-1 knockdown or blockade, including via CsA, enhanced dystrophin-deficient myotube survival.
- Cell death was demonstrated to be dependent on IP3-mediated calcium signaling.
Conclusions:
- CsA exerts a dual modulatory effect on calcium signaling in dystrophin-deficient cells.
- Inhibition of the IP3 pathway, through CsA or other methods, promotes survival of dystrophin-deficient myotubes.
- Targeting the IP3 pathway represents a promising approach to mitigate cell death in dystrophinopathies.
More Related Videos
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
09:11Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
Published on: January 28, 2015
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Ligand-Gated Ion Channel Receptor: Gating Mechanism